The global allergy immunotherapy market reached USD 3.2 billion in 2025. The market is projected to expand at a CAGR of 10.5% from 2026 to 2036, reaching USD 8.7 billion by the end of 2036. Increasing incidence of allergic rhinitis, asthma, food allergies, and insect venom allergies is driving market growth worldwide. Allergy immunotherapy offers long-term symptom relief by targeting the underlying cause of allergic reactions, making it an increasingly preferred treatment option over conventional symptomatic therapies.

Dive Deeper into Data: Get Your In-Depth Sample Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=35708

The growing burden of environmental allergies, coupled with rising exposure to air pollution and changing lifestyles, is significantly boosting demand for allergy immunotherapy solutions. Healthcare providers are increasingly recommending subcutaneous and sublingual immunotherapy for patients seeking long-lasting treatment benefits. Additionally, growing healthcare expenditure, improved diagnostic capabilities, and favorable reimbursement policies in several countries are expected to support market expansion throughout the forecast period.

Technological advancements in allergen extracts, recombinant allergens, precision medicine, and personalized immunotherapy are transforming the allergy immunotherapy market landscape. Manufacturers are focusing on developing safer, more effective, and patient-friendly treatment options with reduced treatment duration and improved clinical outcomes. Furthermore, increasing investments in allergy research and biologic therapies are expected to create new growth opportunities during the forecast period.

Key Findings of the Market Report

• Rising prevalence of allergic diseases is driving demand for immunotherapy treatments.
  ● Sublingual immunotherapy is witnessing increasing adoption due to its convenience.
  ● Personalized allergy treatment approaches are improving patient outcomes.
  ● Technological advancements in allergen formulations are supporting market growth.
  ● Growing awareness of disease-modifying therapies is creating new market opportunities.

Global Allergy Immunotherapy Market: Growth Drivers

• Increasing prevalence of allergic rhinitis, asthma, and food allergies is significantly boosting market growth.
• Growing preference for long-term, disease-modifying treatment over symptomatic therapies is supporting market expansion.
• Advancements in allergen extract technologies and personalized immunotherapy are improving treatment efficacy.
• Rising healthcare investments and improved allergy diagnosis are accelerating product adoption.
• Expanding research in biologics and next-generation immunotherapy solutions is expected to support long-term market growth.

Global Allergy Immunotherapy Market: Regional Landscape

• North America is expected to hold a significant market share owing to the high prevalence of allergic disorders, advanced healthcare infrastructure, and strong adoption of innovative therapies.
• Europe is anticipated to witness steady growth driven by increasing awareness of allergy management, favorable reimbursement policies, and ongoing clinical research.
• Asia Pacific is projected to experience rapid growth due to rising allergy cases, improving healthcare access, and increasing investments in specialty healthcare services.

Global Allergy Immunotherapy Market: Key Players

Leading companies are focusing on innovative allergen formulations, biologic therapies, strategic collaborations, and expansion of immunotherapy product portfolios to strengthen their competitive position.

• ALK-Abelló A/S
  ● Stallergenes Greer
  ● Allergy Therapeutics plc
  ● HAL Allergy Group
  ● Merck KGaA
  ● Aimmune Therapeutics
  ● DBV Technologies
  ● Sanofi

Key Developments

• Companies are investing in recombinant allergen technologies, next-generation biologics, and personalized immunotherapy solutions to improve treatment safety and effectiveness.
• Growing demand for long-term allergy management, minimally invasive therapies, and precision medicine is accelerating innovation across the allergy immunotherapy industry.

Global Allergy Immunotherapy Market: Segmentation

By Treatment Type

• Subcutaneous Immunotherapy (SCIT)
  ● Sublingual Immunotherapy (SLIT)

By Allergy Type

• Allergic Rhinitis
  ● Allergic Asthma
  ● Food Allergy
  ● Insect Venom Allergy
  ● Others

By Distribution Channel

• Hospitals
  ● Specialty Clinics
  ● Retail Pharmacies
  ● Online Pharmacies

By Region

• North America
  ● Europe
  ● Asia Pacific
  ● Latin America
  ● Middle East & Africa

Buy this Premium Research Report:  https://www.transparencymarketresearch.com/checkout.php?rep_id=35708&ltype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com